文献速递细菌感染、耐药与抗菌药物医院感染防控

社区行为干预组合对布基纳法索和刚果(金)抗生素使用及患者管理的影响:整群随机对照试验

Effect of a community-based behavioural intervention bundle to improve antibiotic use and patient management in Burkina Faso and DR Congo (CABU-EICO): a cluster-randomised controlled trial.
PubMed 文献 · Lancet Infect Dis · 2026-06-15

在布基纳法索和刚果(金)开展的整群随机对照试验评估社区行为干预组合对Watch组抗生素使用和患者管理的影响。

要点

  • 干预未对五种常见感染的患者管理评分产生负面影响。
  • 干预包含社区健康教育、对供方的教育反馈及WHO AWaRe指导。

核心结论

  • 行为干预组合与Watch组抗生素使用大幅减少相关,且对患者管理无负面影响。

研究设计与样本

  • 整群随机对照试验,在布基纳法索Nanoro和刚果(金)Kimpese纳入44个村庄或社区(各22个),1:1随机分配至干预组或对照组。
  • 干预为期9个月,共三轮,包括社区健康教育运动和针对供方的教育反馈会议,引入WHO AWaRe抗生素手册指导。
  • 主要结局为通过重复患者调查测量的Watch组抗生素使用从基线到干预后的变化,次要结局为通过模拟患者访问评估的五种常见感染的患者管理评分。

主要发现

  • 基线调查5532名患者,干预后调查4898名患者,共完成1092次模拟患者访问。
  • 患者管理评分变化微小。

临床怎么用

  • 在社区层面实施包含健康教育和对供方教育反馈的行为干预组合,可减少Watch组抗生素使用且不损害患者管理。
  • 减少社区层面广谱抗生素使用可能有助于减缓社区获得性病原体对临床重要抗生素的耐药性上升。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Increasing Watch-group antibiotic use might be contributing to antimicrobial resistance burden in sub-Saharan Africa. We evaluated the effects of a community-based, co-created intervention bundle targeting all community-level health-care providers and the communities they serve on Watch-group antibiotic use and patient management. METHODS: In a cluster-randomised, controlled trial in Nanoro, Burkina Faso, and Kimpese, DR Congo, villages or neighbourhoods with at least 500 inhabitants and at least one community-level or primary-care provider functioning as the main medicine dispenser for the population were randomly allocated (1:1) to intervention or control groups, using the RAND function in Excel. Over 9 months, three intervention rounds consisted of community health education campaigns and educational and feedback sessions with providers, introducing WHO AWaRe (Access, Watch, Reserve) Antibiotic Book guidance for infections with highest antibiotic use. We measured baseline-to-post-intervention changes in Watch-group antibiotic use through repeated patient surveys (100 per provider per village), cluster-adjusted and offset for health-care utilisation (primary outcome), and patient management scores for five common, well defined infections through simulated patient visits (secondary outcome). Providers with fewer than 20 completed surveys at baseline or post-intervention were excluded. Field workers conducting patient surveys and simulated patient visits were masked to group assignment. CABU-EICO was registered on ClinicalTrials.gov (NCT05378880). FINDINGS: 44 villages or neighbourhoods (22 each in Nanoro and Kimpese) were enrolled and randomly assigned to intervention (11 each in Nanoro and Kimpese) or control (11 each in Nanoro and Kimpese) groups. At baseline (Oct 26, 2022, to March 13, 2023), 5532 patients were surveyed (3558 in Nanoro and 1974 in Kimpese). Post-intervention (Nov 6, 2023, to April 3, 2024), 4898 patients (3180 in Nanoro and 1718 in Kimpese) were surveyed. Patients were surveyed at 32 health centres (18 intervention and 14 control), 31 private clinics (15 intervention and 16 control), 45 pharmacies (25 intervention and 20 control), and 41 informal vendors (22 intervention and 19 control). A total of 1092 simulated patient visits were completed across both periods. The weighted prevalence of Watch-group antibiotic use decreased from 26·8% (95% CI 8·8-44·8) to 17·1% (7·7-26·5) in the intervention group and increased from 13·4% (4·8-22·0) to 21·2% (8·9-33·5) in the control group; the adjusted prevalence ratio for use of Watch-group antibiotics was 0·33 (95% CI 0·14-0·78). Changes in patient management scores were minimal. INTERPRETATION: The behavioural intervention bundle was associated with a substantial reduction in Watch-group antibiotic use and no negative effect on patient management, highlighting the potential of antibiotic use improvements across health-care providers. Reduced community-level use of broad-spectrum antibiotics could help slow community-acquired pathogens' increasing resistance to clinically important antibiotics. FUNDING: The Joint Programming Initiative on Antimicrobial Resistance Research and Research Foundation-Flanders. TRANSLATIONS: For the French translation of the abstract see Supplementary Materials section.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ingelbeen B, Valia D, Mbangi B, et al. Effect of a community-based behavioural intervention bundle to improve antibiotic use and patient management in Burkina Faso and DR Congo (CABU-EICO): a cluster-randomised controlled trial. Lancet Infect Dis. 2026. PMID: 42296975. doi:10.1016/S1473-3099(26)00169-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。